FDA Names AI Oral Cancer Detection Technology a Breakthrough Device
The Food and Drug Administration (FDA) has designated Viome’s proprietary mRNA analysis technology, combined with its next generation artificial intelligence (AI) platform, a.
AI in Dentistry
Todays Dental News
Dental Professionals Should Remember the HPV Vaccine Too
We live in a viral world as we patiently await the end of the COVID-19 pandemic. Many people already have chosen to be.
Todays Dental News
Empower Patients to Screen Themselves for Oral Cancer
The number of oral cancer cases and deaths in the United States is concerning. The American Cancer Society estimates that 54,010 people will.
Industry News
Celebrate Oral Cancer Awareness Month This April
April is Oral Cancer Awareness Month, celebrated by a coalition of oral health organizations to educate patients and clinicians alike about the prevalence.
Industry News
Oral Sex Behaviors Impact HPV-Related Cancer Risks
A wide breadth of behaviors surrounding oral sex may affect the risk of oral human papillomavirus (HPV) infection and of a virus-associated head.
Industry News
ACS Updates HPV Vaccination Guidelines
The American Cancer Society (ACS) has updated its guideline for human papillomavirus (HPV) vaccination, adapting a 2019 update from the Federal Advisory Committee.
Todays Dental News
Oral Cancer Awareness Month Amid the COVID-19 Pandemic
I always look forward to April as Oral Cancer Awareness Month with excitement. My calendar is usually filled with free screenings. Each year, I.
Industry News
Vaccines for Boys and Girls Can Eliminate Cancer-Causing HPV
Most of the types of human papillomavirus (HPV) that cause oral and other cancers can be eliminated if both girls and boys are.
Industry News
HPV-Positive Oropharyngeal Cancer Outcomes Differ by Race and Insurance Status
Survival outcomes for oropharyngeal squamous cell carcinoma of the head and neck (SCCHN) positive for the human papillomavirus (HPV) have made significant gains.
Industry News
Botanical Drug Shows Effectiveness Against Head and Neck Cancers
A plant-based drug called APG-157 has shown signs of helping patients fight oral and oropharyngeal cancers, according to a phase I clinical trial.
